Archives
-
WZ4003: A Translational Lens on NUAK Signaling
2026-08-23
WZ4003 offers a mechanistically anchored way to interrogate NUAK1/2 signaling across cancer biology and tau-related neurodegeneration. Its value lies not only in kinase potency, but in the combination of target-engagement controls, phenotype-linked assays, and human brain-slice evidence that can sharpen translational decision-making.
-
Flavopiridol: From CDK Arrest to Translational Insight
2026-08-22
Flavopiridol, also known as L868275, offers translational researchers a way to connect CDK-dependent proliferation with apoptosis, transcriptional control, and cellular stress. This thought-leadership perspective links its cancer research utility to endoplasmic reticulum stress biology while distinguishing established evidence from forward-looking hypotheses.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-08-22
Cy5 NHS ester(Et) is a water-soluble amine-reactive dye for covalent fluorescent labeling of proteins, peptides, and other biomolecules. It is suitable for protein fluorescent labeling, immunofluorescence staining, flow cytometry, and fluorescence microscopy, but not for ethanol-based workflows or long-term storage of prepared dye solutions.
-
Radicicol: Hsp90 Inhibitor Workflows
2026-08-21
Radicicol provides a practical pharmacological probe for Hsp90-dependent signaling across adipocyte differentiation, ovarian carcinoma apoptosis, and immune-cell antigen processing. This guide connects validated product characteristics with executable assay workflows, controls, and troubleshooting strategies for reproducible bench studies.
-
ERK5 and ERK1/2 in Vitamin D–Driven AML Differentiation
2026-08-20
Wang et al. show that ERK5 and ERK1/2 make distinct contributions to 1α,25-dihydroxyvitamin D3-induced differentiation of acute myeloid leukemia cells. Their pharmacological comparison links ERK5 inhibition to altered myeloid marker expression and G1/G2 cell-cycle arrest, while MEK1/2-ERK1/2 inhibition broadly suppresses differentiation-associated markers.
-
CDK4/6 and BET Inhibition in Pancreatic Cancer
2026-08-20
Gu et al. show that palbociclib can restrain PDAC proliferation while paradoxically increasing migration, invasion, and epithelial-to-mesenchymal transition. Combining CDK4/6 inhibition with the BET inhibitor JQ1 restored anti-invasive activity through regulation of GSK3β-mediated Wnt/β-catenin signaling and produced synergistic antitumor effects in vitro and in an orthotopic mouse model.
-
TAI-1: Hec1 Inhibitor Evidence and Workflows
2026-08-19
TAI-1 is a potent Hec1 inhibitor that disrupts Hec1–Nek2 signaling and produces a reported GI50 of 13.48 nM in K562 cells. Product information describes broad anticancer activity, oral efficacy in several preclinical models, and preliminary selectivity findings, while peer-reviewed RB1 organoid research defines a separate biological rationale and important translational limits.
-
WM-8014: From KAT6A Biology to Causal Assays
2026-08-19
WM-8014 is a reversible KAT6A inhibitor for connecting epigenetic perturbation with senescence, cell-cycle, and tumor-growth phenotypes. This guide shows how to translate time-gated CRISPR insights into better causal assays while defining the compound’s practical limits.
-
Z-WEHD-FMK in Pyroptosis and Caspase Research
2026-08-18
Z-WEHD-FMK provides cell-permeable, irreversible inhibition of inflammatory caspases for dissecting pyroptosis, infection-associated Golgi remodeling, and caspase-dependent cell death. This guide translates the HOXC8–caspase-1 study into practical assay designs while highlighting solvent control, timing, and specificity considerations.
-
U 46619: From TP Signaling to Translation
2026-08-18
U 46619, also known as 11,9 epoxymethano-prostaglandin H2, provides a controllable TP-receptor stimulus for connecting platelet signaling, vascular tone, renal hemodynamics, and hypertension models. This thought-leadership guide shows how to use concentration-resolved phenotyping and disciplined translational boundaries to turn a potent research agonist into a strategic experimental benchmark.
-
Protease & Phosphatase Inhibitor Cocktail Guide
2026-08-17
Explore how a Protease and Phosphatase Inhibitor Cocktail preserves both protein abundance and phosphorylation state. This guide connects EDTA-free inhibitor selection to PTGER4–HDAC signaling assays, organoid workflows, and evidence-based sample handling.
-
Filipin III for Cholesterol Membrane Workflows
2026-08-17
Filipin III enables practical cholesterol mapping across cells, membrane fractions, vesicles, and freeze-fracture electron microscopy workflows. This guide connects probe handling and assay controls with the caveolin-1 findings reported in MASLD, while clearly separating exploratory assay recommendations from disease-mechanism evidence.
-
TPCA-1 and the NF-κB–Apaf1 Axis
2026-08-16
TPCA-1 offers a selective way to interrogate IKK-2-driven inflammation and its potential connection to the NF-κB/Apaf1/caspase-9/autophagy axis identified in septic acute kidney injury. This thought-leadership analysis translates evidence from rheumatoid arthritis models into a disciplined framework for testing tubular inflammation, apoptosis, and autophagy without overstating preclinical findings.
-
Hepatic sEH–Nrf2 Axis in Osteoporosis
2026-08-15
The reference study identifies hepatic soluble epoxide hydrolase as an upstream regulator of osteoclast differentiation through circulating 14,15-EET, 14,15-DHET, inflammatory cytokines, and the Nrf2–ARE pathway. Its combination of patient samples, ovariectomy-induced osteoporosis, liver-specific intervention, and cell-based experiments provides a mechanistic framework for studying the liver–bone axis and evaluating sEH inhibition in bone-loss research.
-
MHY1485: mTOR Activator for Autophagy Assays
2026-08-14
MHY1485 provides a practical way to activate mTOR signaling while testing autophagy suppression, cell growth, and survival phenotypes. This workflow-focused guide connects pathway readouts with the LMP2A–mTORC1–GCNT3 findings reported in nasopharyngeal carcinoma and highlights controls that prevent misinterpreting LC3II accumulation.